Cargando…
Probing the competitive inhibitor efficacy of frog-skin alpha helical AMPs identified against ACE2 binding to SARS-CoV-2 S1 spike protein as therapeutic scaffold to prevent COVID-19
In COVID-19 infection, the SARS-CoV-2 spike protein S1 interacts to the ACE2 receptor of human host, instigating the viral infection. To examine the competitive inhibitor efficacy of broad spectrum alpha helical AMPs extracted from frog skin, a comparative study of intermolecular interactions betwee...
Autores principales: | Sekar, P. Chandra, Srinivasan, E., Chandrasekhar, G., Paul, D. Meshach, Sanjay, G., Surya, S., Kumar, NS. Arun Raj, Rajasekaran, R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9034900/ https://www.ncbi.nlm.nih.gov/pubmed/35461388 http://dx.doi.org/10.1007/s00894-022-05117-8 |
Ejemplares similares
-
Could Dermaseptin Analogue be a Competitive Inhibitor for ACE2 Towards Binding with Viral Spike Protein Causing COVID19?: Computational Investigation
por: Sekar, P. Chandra, et al.
Publicado: (2021) -
Spike residue 403 affects binding of coronavirus spikes to human ACE2
por: Zech, Fabian, et al.
Publicado: (2021) -
Ultrastructural changes and cyclic AMP in frog oxyntic cells
Publicado: (1978) -
Mechanism and evolution of human ACE2 binding by SARS-CoV-2 spike
por: Wrobel, Antoni G.
Publicado: (2023) -
Competitive SARS-CoV-2 Serology Reveals Most Antibodies Targeting the Spike Receptor-Binding Domain Compete for ACE2 Binding
por: Byrnes, James R., et al.
Publicado: (2020)